Trump's regulatory agenda would face challenges in a second term.

The article discusses the regulatory priorities that the U.S. President Donald Trump Administration needs to focus on if he is elected to a second term and looks at the legal challenges that would affect these agenda. Topics mentioned include the economic consequences of the COVID-19 pandemic, the demand for lower prescription drug prices, and the expansion of the value-based payment in Medicare and Medicaid programs.